Conditions: Neoplasm Metastasis Palliative Care
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 59
Healthy volunteers: no

Brief summary:
The purpose of this study is to investigate the safety and efficacy of tanezumab in combination with opioids in treating pain due to cancer that has spread to bone.

Detailed description:

Arms:
arm 1: None arm 2: Single IV infusion of placebo for tanezumab on Day 1. Maintained on baseline opioid regimen.

Interventions: intervention 1: Tanezumab 10 mg IV intervention 2: IV Placebo for tanezumab
Intervention descriptions: intervention 1: Single IV infusion of 10 mg tanezumab on Day 1. Maintained on baseline opioid regimen. intervention 2: Single IV infusion of placebo for tanezumab on Day 1. Maintained on baseline opioid regimen.

Protocol document: